Abstract
The first clinical case is that of a child with renal hypo-dysplasia and several nonrenal comorbidities and on peritoneal dialysis since the neonatal period. He underwent two abdominal interventions due to intestinal necrosis plus repeated peritoneal catheter replacements. At the age of 2 years, he experienced a methicillin-resistant Staphylococcus aureus (MRSA) peritonitis originated from an exit-site/tunnel infection caused by the same organism. Peritonitis was effectively cured with intraperitoneal vancomycin, while persistent and antibiotic-resistant exit-site and tunnel infection was treated with local debridement and curettage, unroofing of the subcutaneous tunnel, and extrusion and shaving of the external Dacron cuff of the catheter. In this small child, local, conservative surgery was performed as an alternative to catheter removal taking into account his history of repeated catheter replacements and high operative risk.
The second clinical case initially presented as an almost ordinary case of peritonitis in an apparently not-at-risk 4-year-old child who had been on peritoneal dialysis for 26 months. On day 3 of treatment, culture results showed that peritonitis was caused by a strain of Candida parapsilosis, whose occurrence and growth could have been facilitated by repeated, short courses of antibiotic treatment of recurrent urinary tract infections in a child with complex urinary tract abnormalities. After 2 days of treatment with fluconazole and no clinical improvement, the peritoneal catheter was removed, and fluconazole was replaced by caspofungin, by which the fungal infection was effectively treated. Serial determinations of 1-3-β-D-glucan in serum and peritoneal fluid, together with concomitant evaluation of clinical conditions and microbiology, were helpful to assess response to therapy and to optimize the timing of peritoneal catheter replacement.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schaefer F, Klaus G, Mueller-Wiefel DE, Mehls O. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis peritonitis. J Am Soc Nephrol. 1999;10:136–45.
Warady BA, Bakkaloglu S, Newland J, Cantwell M, Verrina E, Neu A, Chadha V, Yap HK, Schaefer F. Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int. 2012;32(Suppl 2):S32–86.
Marrie TJ, Noble MA, Costerton JW. Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy. J Clin Microbiol. 1983;18(6):1388–98.
Stuart S, Booth TC, Cash CJ, Hameeduddin A, Goode JA, Harvey C, Malhotra A. Complications of continuous ambulatory peritoneal dialysis. Radiographics. 2009;29(2):441–60.
Crabtree JH, Burchette RJ. Surgical salvage of peritoneal dialysis catheters from chronic exit-site and tunnel infections. Am J Surg. 2005;190(1):4–8.
Macchini F, Testa S, Valadè A, Torricelli M, Leva E, Ardissino G, Edefonti A. Conservative surgical management of catheter infections in children on peritoneal dialysis. Pediatr Surg Int. 2009;25(8):703–7. Epub 2009 Jul 2.
Zurowska A, Feneberg R, Warady BA, Zimmering M, Monteverde M, Testa S, Calyskan S, Drozdz D, Salusky I, Kemper MJ, Ekim M, Verrina E, Misselwitz J, Schaefer F. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. Am J Kidney Dis. 2008;51:455–62.
Warady BA, Feneberg R, Verrina E, Flynn JT, Muller-Wiefel DE, Besbas N, Zurowska A, Aksu N, Fischbach M, Sojo E, Donmez O, Sever L, Sirin A, Alexander SR, Schaefer F. Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol. 2007;18:2172–9.
North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) 2011 Annual Report (http://www.naprtcs.org).
Warady BA, Bashir M, Donaldson LA. Fungal peritonitis in children receiving peritoneal dialysis: a report of the NAPRTCS. Kidney Int. 2000;58:384–9.
Raaijmakers R, Schroeder C, Monnens L, Cornelissen E, Warris A. Fungal peritonitis in children on peritoneal dialysis. Pediatr Nephrol. 2007;22:288–93.
Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O. β-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the third European conference on infections in leukemia (ECIL-3). Clin Infect Dis. 2012;54(5):633–43.
Mohr JF, Sims C, Paetznick V, Rodriguez J, Finkelman MA, Rex JH, Ostrosky-Zeichner L. Prospective survey of (1-3)-β-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol. 2011;49:58–61.
Marchetti M, Chakrabarti A, Colizza S, Garnacho-Montero J, Kett DH, Munoz P, Cristini F, Andoniadou A, Viale P, Rocca GD, Roilides E, Sganga G, Walsh TJ, Tascini C, Tumbarello M, Menichetti F, Righi E, Eckmann C, Viscoli C, Shorr AF, Leroy O, Petrikos G, De Rosa FG. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med. 2013;39(12):2092–106.
Worasilchai N, Leelahavanichkul A, Kanjanabuch T, Thongbor N, Lorvinitnun P, Sukhontasing K, Finkelman M, Chindamporn A. (1→3)-β-D-glucan and galactomannan testing for the diagnosis of fungal peritonitis in peritoneal dialysis patients, a pilot study. Med. Mycol. 2015;53(4):338–46.
Ginocchio F, Verrina E, Furfaro E, Cannavò R, Bandettini R, Castagnola E. Case report of the reliability 1,3-β-D-glucan monitoring during treatment of peritoneal candidiasis in a child receiving continuous peritoneal dialysis. Clin Vaccine Immunol. 2012;19(4):626-627. Epub 2012 Feb 22.
Kanda H, Kubo K, Hamasaki K, Kanda Y, Nakao A, Kitamura T, Fujita T, Yamamoto K, Mimura T. Influence of various hemodialysis membranes on the plasma (1/3)- β-D-glucan level. Kidney Int. 2001;60:319–23.
Kale-Pradhan PB, Morgan G, Wilhelm SM, Johnson LB. Comparative efficacy of echinocandins and nonechinocandis for the treatment of Candida parapsilosis infections: a meta-analysis. Pharmacotherapy. 2010;30:1207–13.
Acknowledgments
The author would like to thank Dr. Elio Castagnola for clinical consultation on infectious disease issues, Dr. Roberto Bandettini for laboratory analyses, and Dr. Alessio Pini Prato for surgical consultation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Verrina, E.E. (2017). Peritonitis. In: Warady, B., Schaefer, F., Alexander, S. (eds) Pediatric Dialysis Case Studies. Springer, Cham. https://doi.org/10.1007/978-3-319-55147-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-55147-0_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55145-6
Online ISBN: 978-3-319-55147-0
eBook Packages: MedicineMedicine (R0)